COMMUNIQUÉS West-GlobeNewswire

NTS Ventures and IHMA Announce a Significant and Important Program Focusing on Antifungal Resistance Surveillance: STAR (Susceptibility Trends in Antifungal Resistance)
12/06/2019
SCHAUMBURG, Ill., June 12, 2019 (GLOBE NEWSWIRE) -- NTS Ventures (NTS), a mycology and antifungal clinical research laboratory and International Health Management Associates, Inc./IHMA Europe Sàrl (IHMA), a full-service [...]
Mersana Therapeutics Announces Appointment of Brian C. DeSchuytner as Senior Vice President of Finance and Product Strategy
12/06/2019
Brings Significant Strategic and Operational Experience from Leading Oncology Companies Company Announces Chief Financial Officer Transition CAMBRIDGE, Mass., June 12, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc [...]
NTS Ventures et IHMA annoncent un programme significatif et important axé sur la surveillance de la résistance aux antifongiques : STAR (Tendances de susceptibilité de la résistance aux antifongiques)
12/06/2019
SCHAUMBURG, Illinois, 12 juin 2019 (GLOBE NEWSWIRE) -- NTS Ventures (NTS), un laboratoire de recherche clinique sur la mycologie et les antifongiques, et International Health Management Associates, Inc./IHMA Europe Sàrl [...]
Otonomy to Present at the Raymond James Life Sciences and MedTech Conference
12/06/2019
SAN DIEGO, June 12, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that David A. Weber, Ph.D [...]
INSYS Therapeutics, Inc. Receives Court Approval of “First Day” Motions
12/06/2019
Operations to Continue in the Ordinary Course During Court-Supervised Process PHOENIX, June 12, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY) (“INSYS” or the “Company”), a specialty pharmaceutical [...]
BioCardia Announces Issuance of Chinese Patent for Image-Guided Biotherapeutic Delivery
12/06/2019
SAN CARLOS, Calif., June 12, 2019 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the China [...]
Wave Life Sciences to Present at Parent Project Muscular Dystrophy 2019 Annual Conference
12/06/2019
CAMBRIDGE, Mass., June 12, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating [...]
Neos Therapeutics to Present at Two Upcoming June Conferences
12/06/2019
DALLAS and FORT WORTH, Texas, June 12, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) [...]
Predictive Oncology Inc. (Formerly Precision Therapeutics) Names Amelia Warner, Pharm.D., RPh, as Interim Chief Operating Officer of Helomics
12/06/2019
MINNEAPOLIS, June 12, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: AIPT) (“Predictive Oncology” or the “Company”), a company focused on applying artificial intelligence to personalized medicine and drug [...]
Selecta Biosciences Presents Full Data from Phase 2 Trial of SEL-212 for Chronic Refractory Gout at EULAR 2019
12/06/2019
WATERTOWN, Mass., June 12, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its immune [...]
Soleno Therapeutics Announces Appointment of Veteran Industry Executive Birgitte Volck, M.D., Ph.D., to Board of Directors
12/06/2019
REDWOOD CITY, Calif., June 12, 2019 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]
Crown Bioscience Announces Four New Preclinical NASH Models In Development
12/06/2019
- Reaffirms Commitment to NASH Drug Discovery - SAN DIEGO, June 12, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance [...]
HempAmericana CEO Addresses Company Expansion Following Strong Orders
12/06/2019
NEW YORK, June 12, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) CEO issues the following letter to Shareholders: Dear Valued Shareholder, As we begin to [...]
Tauri-Gum Successfully Penetrates New York City Metro Area Marketplace; Product Now Available at More than 250 Distinct Retail Stores and Locations
12/06/2019
NEW YORK, NY, June 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]
Kiniksa Presents Preclinical Data on the GM-CSF Signaling Pathway in Temporal Arteries of GCA Patients at the Annual European Congress of Rheumatology
12/06/2019
- Preclinical data support rationale for targeting GM-CSF in GCA – - Mavrilimumab shows biological effect on genes relevant to GCA pathophysiology in ex vivo cultures of GCA arteries – HAMILTON, Bermuda, June 12, 2019 ( [...]
Strongbridge Biopharma plc to Present at the 2019 JMP Securities Life Sciences Conference
12/06/2019
DUBLIN, Ireland and TREVOSE, Pa., June 12, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
T2 Biosystems to Highlight its Products and Technology at Upcoming Medical Meetings
12/06/2019
LEXINGTON, Mass., June 12, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it will [...]
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended 30 April 2019
12/06/2019
Summit Therapeutics plc (‘Summit’, the ‘Company’ or the ‘Group’) Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended 30 April 2019 Oxford, UK, and Cambridge, MA, US, 12 [...]
Sorrento to Explore Potential Initial Public Offering of Scilex Holding Company
12/06/2019
SAN DIEGO, June 12, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Sorrento, Nasdaq: SRNE) today announced that it is exploring the possibility of an initial public offering of its majority-owned subsidiary, [...]

Pages